KLOW blend side effects and risks

Reported side effects

• Injection-site pain, redness, welts or bruising: Self reports without a denominator; no reliable KLOW reaction rate., moderate. Pause for persistent reactions; spreading heat or redness needs prompt assessment. (source)
• Serious allergic or immune reaction: FDA flags immune reaction risk; blend incidence is unknown., serious. Breathing trouble, throat swelling or collapse needs emergency care. (source)
• Infection from a contaminated injection: Product related risk; no measured blend rate., serious. Seek urgent care for fever with spreading redness or severe injection-site pain. (source)

Stop and get help if

• Trouble breathing, throat swelling, collapse or fainting after an injection: Stop and call emergency services now.
• Hot, painful, spreading redness or swelling at an injection site: Stop injections and seek urgent same-day care; fever, confusion or fast breathing needs emergency care.

Who should avoid it

• pregnant: Precaution: adequate pregnancy safety data for the four-ingredient blend are absent.
• breastfeeding: Precaution: milk transfer and infant effects have not been studied for the four-ingredient blend.
• tryingToConceive: Precaution: reproductive safety and a safe washout period are unknown.
• under18: Precaution: no pediatric four-ingredient blend safety or dosing studies found.
• activeCancer: Precaution: ingredients promote blood-vessel growth in lab studies; effects on human tumors are unknown.
• cancerHistory: Review prior cancer with the treating clinician; long-term tumor effects have not been measured.
• kidneyDisease: Blend clearance and dose changes in kidney disease are unknown.
• liverDisease: Blend clearance and dose changes in liver disease are unknown.
• bleedingDisorder: Precaution for needle-related bruising and bleeding, especially with muscle injection.
• surgeryPlanned: Tell the surgical team about all ingredients; no safe perioperative stopping interval is established.
• testedAthlete: BPC-157 and TB-500 are prohibited at all times under the 2026 WADA list.
• other: Avoid re-exposure after a serious reaction; peptide impurities can trigger immune reactions.
• other: Precaution: GHK-Cu adds copper exposure; copper buildup can damage organs. No safe injectable four-ingredient blend dose is established.

Interactions

• Additional GHK-Cu or copper supplements: Adds copper exposure. No KLOW interaction study defines safe combined amounts, and oral copper limits cannot be used as injection limits.
• Other BPC-157, TB-500, thymosin beta-4 or KPV products: Duplicates ingredients or adds a different thymosin molecule. Combined safety and a reliable total exposure cannot be inferred from the blend name.

Product quality risks

• Label names may hide different TB4 molecules; fragment and full-length products are not interchangeable.
• FDA-reviewed ingredient COAs lacked some content, aggregate or endotoxin controls. HPLC purity alone cannot establish injection safety.
• Unauthorized injections may have wrong amounts, undeclared ingredients, microbes or endotoxins; blend defect rates are unknown.